Ketamine

Recent articles

Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.

Ketamine targets lateral habenula, setting off cascade of antidepressant effects

The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.

By Olivia Gieger
4 September 2024 | 6 min read

Explore more from The Transmitter

Hand holding a vial of microplastics.

Measuring plastic in the brain: Improving, but incomplete

Meanwhile, researchers are publishing papers without “sufficient quality control,” says analytical chemist Dušan Materić.

By Amber Dance
18 September 2026 | 9 min read
Calendar with deadline.

Incredible shrinking grant deadlines at the BRAIN Initiative

“A month is crazy,” says one former recipient, referring to a new funding opportunity’s timeline.

By Brendan Borrell
17 September 2026 | 4 min read

Sylvia Fogel, reshaping U.S. autism research strategy

In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.

By Brady Huggett
17 September 2026 | 1 min read